Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis

British Journal of Dermatology

Volumn 147, Issue 6, 2002, Pages 1109-1117

  Smith, A D ^a   Streilein, R D ^a   Hall III, Russell P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD11b; Dermatitis herpetiformis; Mucosal immunity; Neutrophils

Indexed keywords

ANTIGEN; CD11B ANTIGEN; CD89 ANTIGEN; DAPSONE; FC RECEPTOR; IMMUNOGLOBULIN A RECEPTOR; IMMUNOGLOBULIN RECEPTOR; L SELECTIN; SULFAPYRIDINE; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; IMMUNOGLOBULIN A; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CELIAC DISEASE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GEOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; SKIN DEFECT; SKIN PAPILLOMA; STATISTICAL SIGNIFICANCE; BLOOD; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; MUCOSAL IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD11B; DERMATITIS HERPETIFORMIS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; L-SELECTIN; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, FC;

EID: 0036886645     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.05004.x     Document Type: Article

References (33)

1. Hall RP III Dermatitis herpetiformis. J Invest Dermatol 1992; 99: 873-81.
2. Keogh M, Hall RP III. Dermatitis herpetiformis. In: Cutaneous Medicine and Surgery (Arndt KD, Robinson JK, LeBoit PE et al., eds). Philadelphia: W.B.Saunders Co., 1996; 691-7.
3. Fry L. Dermatitis herpetiformis. Baillieres Clin Gastroenterol 1995; 9: 371-93.
4. Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet 1966; ii: 1280-2.
5. Fry L, Keir P, McMinn RMH. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet 1967; ii: 729-33.
6. Fry L, Leonard JN, Swain F et al. Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 1982; 107: 631-40.
7. Leonard J, Haffenden G, Tucker W et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983; 308: 816-19.
8. Brown E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol 1997; 34: 319-26.
9. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
10. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6.
11. Socinski MA, Cannistra SA, Sullivan R et al. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 1988; 72: 691-7.
12. Griffin ID, Spertini O, Ernst TJ et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes and their precursors. J Immunol 1990; 145: 576-84.
13. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998; 94: 461-71.
14. Burg ND. Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 7-17.
15. Dieterich W, Laag E, Schopper H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-21.
16. Hall RP III, McKenzie KD. Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis. Clin Immunol Immunopathol 1997; 62: 33-41.
17. Katz SI, Hall RP III, Lawley TJ, Strober W. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med 1980; 93: 857-74.
18. Blenkinsopp WK, Haffenden GP, Fry L et al. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol 1983; 5: 547-54.
19. Hendrix JD, Mangum KL, Zone JJ et al. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 1990; 94: 667-72.
20. Weisbart RH, Kacena A, Schuh A et al. GM-CSF induces human neutrophil IgA mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988; 332: 647-8.
21. Lee RT, Briggs WH, Cheng GC et al. Mechanical deformation promotes secretion of IL-1alpha and IL-1 receptor antagonist. J Immunol 1997; 159: 5084-8.
22. Condliffe AM, Chilvers ER, Haslett C. Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 1996; 89: 105-11.
23. Xiao F, Eppihimer MJ, Young JA et al. Lung neutrophil retention and injury after intestinal ischemia/reperfusion. Microcirculation 1997; 4: 359-67.
24. Hansbrough JF, Wikstrom T, Braide M et al. Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit Care Med 1996; 24: 1366-72.
25. Smith AD, Bagheri B, Streilein RD et al. Expression of interleukin-4 and interferon-γ in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci 1999; 44: 2124-32.
26. Nilsen EM, Jahnsen FL, Lundin KEA et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-33.
27. Przemioslo RT, Kontakou M, Nobili V et al. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994; 35: 1398-403.
28. Ward MM, Pisetsky DS, Hall KP III. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis. J Invest Dermatol 1991; 97: 568-72.
29. Crabtree JE, Heatley RV, Juby LD et al. Soluble interleukin-2 receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol 1989; 77: 345-8.
30. Jelinkova L, Tuckova L, Sanchez D et al. Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease. Dig Dis Sci 2000; 45: 398-402.
31. Bernstein CN, Sargent M, Rawsthorne P et al. Peripheral blood lymphocyte β2 integrin and ICAM expression in inflammatory bowel disease. Dig Dis Sci 1997; 42: 2338-49.
32. Modschiedler K, Weller M. Worl P et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. Arch Dermatol Res 2000; 292: 32-6.
33. Zuidema J, Hilbers-Modderman ESM, Merkus FWHM. Clinical pharmacokinetics of dapsone. Clin Pharmacokinetics 1986; 11: 299-315.